Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Steel Authority of India Limited (SAIL) has officially announced the date for revealing its Q2 FY2025 financial results. Discover when investors can expect the earnings report and what analysts are predicting for the state-owned metal giant.
EPACK Prefab Technologies continues its spectacular run with another 15% surge as investor enthusiasm builds following strong quarterly results. Discover what's driving this remarkable performance.
In the high-stakes Indian EV race, Ather Energy delivered staggering 240% returns to shareholders while Ola Electric investors lost significant wealth. Discover the contrasting journeys of these electric scooter giants.
Indian aluminium giants surge as global prices hit multi-month highs. Discover which stocks gained the most and what's driving this bullish trend in metal markets.
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Discover expert stock recommendations from Vaishali Parekh of Prabhudas Lilladher for today's trading session. Get insights on HDFC Bank, Tata Steel, and Reliance Industries with specific buy/sell levels and targets.
Market expert Raja Venkatraman shares his top stock recommendations for October 2024, offering insights on Nifty, Sensex trends and sectors poised for growth in current market conditions.
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Indian stock markets closed with modest gains after a roller-coaster session. While banking and auto stocks provided support, late-day profit-taking erased most intraday advances. Key factors driving market sentiment and what experts predict next.
Mumbai Crime Branch arrests wanted drug smuggler Lalit Patil after massive nationwide manhunt in connection with record ₹252 crore pharmaceutical drug seizure case.
Discover how a little-known small-cap stock under ₹50 stunned investors with a massive 20% surge following a crucial business development. Find out what triggered this explosive rally and whether the momentum can continue.
Expert technical analyst Nagaraj Shetti reveals why IDFC First Bank and Central Bank of India shares could deliver strong returns in the coming sessions. Get the complete technical breakdown and trading strategy.
Discover how one NSE SME-listed company defied market expectations with staggering 150% returns over three years, turning early investors into millionaires despite its unremarkable stock market beginning.
Investment experts warn retail investors about the hidden dangers of direct mid and small-cap stock investments. Discover why mutual funds might be the safer choice for market exposure.
Expert stock picks from Mehta Equities reveal promising short-term opportunities in Bharti Airtel, Motilal Oswal, and PayTM. Discover key technical levels and investment strategies.
Get exclusive insights from market veteran Raja Venkatraman as he shares his top stock recommendations for October. Discover which sectors and specific companies are poised for significant growth in the current market scenario.
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Nifty 50 surges near all-time peak as banking and IT stocks lead rally. Analysts predict potential breakout with strong FII inflows and global market support.
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Chinese and Hong Kong equities faced downward pressure as gold stocks dragged major indices lower. Persistent trade tensions and anticipation around China's Third Plenum kept investors cautious. Get the latest market analysis and key sector performances.
Ace investor Ashish Kacholia increases his stake in Aeroflex Industries during Q2, signaling strong confidence in this small-cap stock that has delivered multibagger returns. Discover why this move matters for retail investors.
Japan's Nikkei 225 surges to unprecedented levels as government plans new economic stimulus package, boosting investor confidence and market sentiment across Asia.